Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLAMF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400499 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATS2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGAG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MVP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPYD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKR1B10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPSTI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC15A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on